TrialEuropean child & adolescent psychiatry2014

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.

David R Coghill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.